OTCMKTS:RDSMY - Koninklijke DSM Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $178.00
  • Forecasted Upside: 385.81 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$36.64
▲ +0.69 (1.92%)

This chart shows the closing price for RDSMY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Koninklijke DSM Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RDSMY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RDSMY

Analyst Price Target is $178.00
▲ +385.81% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Koninklijke DSM in the last 3 months. The average price target is $178.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 385.81% upside from the last price of $36.64.

This chart shows the closing price for RDSMY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 polled investment analysts is to buy stock in Koninklijke DSM. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/10/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/7/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/5/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/5/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/4/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/4/2022

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/24/2022Deutsche Bank AktiengesellschaftLower Price TargetBuy ➝ Buy€205.00 ➝ €180.00
6/14/2022Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform
5/25/2022BarclaysLower Price Target€189.00 ➝ €188.00
3/31/2022UBS GroupLower Price TargetBuy ➝ Buy€190.00 ➝ €185.00
3/29/2022BarclaysLower Price Target€193.00 ➝ €189.00
3/28/2022Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight€166.00 ➝ €155.00
2/23/2022BarclaysBoost Price Target€192.00 ➝ €193.00
2/23/2022Societe GeneraleUpgradeHold ➝ Buy
2/17/2022Credit Suisse GroupLower Price TargetOutperform ➝ Outperform€205.00 ➝ €182.00
2/16/2022UBS GroupLower Price TargetBuy ➝ Buy€205.00 ➝ €190.00
1/12/2022Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform
11/3/2021Morgan StanleyReiterated RatingEqual Weight
10/22/2021CitigroupReiterated RatingBuy
10/12/2021BarclaysBoost Price TargetOverweight€189.00 ➝ €195.00
9/30/2021Credit Suisse GroupReiterated RatingOutperform
9/16/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/15/2021ING GroupUpgradeSell ➝ Buy
9/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/2/2021BarclaysBoost Price TargetOverweight ➝ Overweight€168.00 ➝ €189.00
9/1/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
8/24/2021UBS GroupReiterated RatingBuy
8/4/2021Morgan StanleyReiterated RatingEqual Weight
8/4/2021Societe GeneraleReiterated RatingHold
7/14/2021UBS GroupReiterated RatingBuy
7/9/2021Morgan StanleyReiterated RatingEqual Weight
7/7/2021JPMorgan Chase & Co.Reiterated RatingOverweight
5/18/2021BarclaysUpgradeOverweight
4/19/2021JPMorgan Chase & Co.Initiated CoverageOverweight
2/17/2021BarclaysReiterated RatingOverweight
2/17/2021UBS GroupReiterated RatingBuy
2/17/2021Credit Suisse GroupReiterated RatingOutperform
1/20/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform
1/12/2021Sanford C. BernsteinDowngradeMarket Perform ➝ Underperform
11/10/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
11/4/2020Credit Suisse GroupReiterated RatingNeutral
10/14/2020Morgan StanleyReiterated RatingEqual Weight
10/1/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
7/24/2020Main First BankUpgradeHold ➝ Buy
7/15/2020Credit Suisse GroupReiterated RatingNeutral
7/8/2020UBS GroupReiterated RatingBuy
7/6/2020Credit Suisse GroupReiterated RatingNeutral
6/29/2020JPMorgan Chase & Co.Reiterated RatingOverweight
5/13/2020JPMorgan Chase & Co.Reiterated RatingOverweight
4/29/2020ING GroupDowngradeHold ➝ Sell
4/15/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/30/2020Morgan StanleyReiterated RatingEqual Weight
3/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight
11/27/2019Sanford C. BernsteinDowngradeMarket Perform ➝ Underperform
8/5/2019ABN AmroDowngradeBuy ➝ Hold
7/5/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
2/1/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy
11/29/2018MacquarieInitiated CoverageOutperform ➝ Outperform
12/1/2017Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.58 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/6/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/4/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/6/2022
  • 5 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/5/2022
  • 6 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/5/2022
  • 5 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/4/2022
  • 3 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/4/2022

Current Sentiment

  • 3 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Koninklijke DSM logo
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Read More

Today's Range

Now: $36.64
Low: $35.83
High: $36.64

50 Day Range

MA: $38.45
Low: $34.47
High: $42.44

52 Week Range

Now: $36.64
Low: $34.13
High: $56.92

Volume

48,700 shs

Average Volume

66,704 shs

Market Capitalization

$25.62 billion

P/E Ratio

N/A

Dividend Yield

1.99%

Beta

0.95

Frequently Asked Questions

What sell-side analysts currently cover shares of Koninklijke DSM?

The following Wall Street sell-side analysts have issued reports on Koninklijke DSM in the last twelve months: Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, ING Group, JPMorgan Chase & Co., Morgan Stanley, Sanford C. Bernstein, Societe Generale, and UBS Group AG.
View the latest analyst ratings for RDSMY.

What is the current price target for Koninklijke DSM?

0 Wall Street analysts have set twelve-month price targets for Koninklijke DSM in the last year. Their average twelve-month price target is $178.00, suggesting a possible upside of 385.8%.
View the latest price targets for RDSMY.

What is the current consensus analyst rating for Koninklijke DSM?

Koninklijke DSM currently has 2 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RDSMY will outperform the market and that investors should add to their positions of Koninklijke DSM.
View the latest ratings for RDSMY.

What other companies compete with Koninklijke DSM?

How do I contact Koninklijke DSM's investor relations team?

Koninklijke DSM's physical mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The basic materials company's listed phone number is (145) 578-8111. The official website for Koninklijke DSM is www.dsm.com. Learn More about contacing Koninklijke DSM investor relations.